CellSource Co

CellSource Co ROIC

The Return on Invested Capital (ROIC) of CellSource Co (4880.T) as of Oct 27, 2026 is 0.18 %. In the previous year, Return on Invested Capital (ROIC) was 3.89 % — a change of -95.49% (lower).

ROIC

0.18 %

YoY

-95.49%

Last updated:

Return on Invested Capital (ROIC) of CellSource Co is 2025 0.18 % . Return on Invested Capital (ROIC) of CellSource Co was 2024 3.89 % . It decreases by -95.49% lower compared to the previous year.

The CellSource Co ROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROIC
Date
ROIC
Jan 1, 2018
48.20 JPY
Jan 1, 2019
12.36 JPY
Jan 1, 2020
13.39 JPY
Jan 1, 2021
23.94 JPY
Jan 1, 2022
26.89 JPY
Jan 1, 2023
14.65 JPY
Jan 1, 2024
3.89 JPY
Jan 1, 2025
0.18 JPY
The CellSource Co ROIC history
YEARROICYoY
0.18 %-95.49%
3.89 %-73.44%
14.65 %-45.50%
26.89 %+12.33%
23.94 %+78.75%
13.39 %+8.35%
12.36 %-74.36%
48.20 %-10.07%
53.60 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CellSource Co Stock analysis

What does CellSource Co do? CellSource Co., Ltd. generates revenue through its Regenerative Medicine Related business segment, which provides contracted services for processing tissues and cells from fat and blood to medical institutions, along with support services for regenerative medicine laws and regulations related to safety assurance. The company also sells medical equipment within this segment. The Consumer business segment focuses on selling cosmetics and facial products directly to general consumers. Both segments operate under the company's brand without additional brand names mentioned in the description. The Regenerative Medicine Related business segment targets medical institutions and regulatory compliance support for regenerative medicine safety, while the Consumer business segment serves general consumers seeking cosmetics and facial care products. The company's products include processed tissue and cell services, regulatory support, medical equipment, and consumer skincare items, all sold under the CellSource brand. CellSource Co., Ltd. employs 109 full-time employees to manage its two business segments, with the Regenerative Medicine Related segment handling medical services and equipment sales, and the Consumer segment focusing on direct-to-consumer product sales. The company's revenue streams are derived from these two distinct operational areas without any additional external partnerships or third-party brands. CellSource Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CellSource Co stock

Return on Invested Capital (ROIC) of CellSource Co is 0.18 % in 2025.

Return on Invested Capital (ROIC) of CellSource Co changed from 3.89 % to 0.18 %, representing a -95.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Invested Capital (ROIC) CellSource Co since 2006 – with annual values, charts, and detailed analysis.

ROIC measures how effectively a company uses its invested capital to generate profits. A ROIC above the cost of capital creates shareholder value.

ROIC = NOPAT / Invested Capital

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Invested Capital (ROIC)'s CellSource Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Invested Capital (ROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Invested Capital (ROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — CellSource Co

All Key Metrics — CellSource Co